Back to search
Intestinal Tuberculosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Intestinal Tuberculosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Intestinal Tuberculosis trials you may qualify forThis study adopts a combined design of retrospective cohort study followed by prospective observational study, which is conducted at Beijing Chest Hospital. The…
Differentiating CD from intestinal tuberculosis (ITB) is difficult due to the low sensitivities of currently available diagnostic tests. The Asia-Pacific guidel…
This will be the first study to evaluate the use of Nyaditum resae® as a potential agent for reducing antibiotic-associated gut dysbiosis in patients with drug-…
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a deadly infectious disease and major global public health problem. Recent evidence from anima…
Anti-Tuberculosis Treatment (ATT) is one of the effective treatments of tuberculosis but the use of drugs for a long time put an adverse effect on the gut and o…